Peter Van Loo
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 37
- Oncology top 1%
- Molecular Biology top 1%
- Genomics and Phylogenetic Studies 9
- Epigenetics and DNA Methylation 8
- Single-cell and spatial transcriptomics 7
- Gene expression and cancer classification 7
- Genomics and Chromatin Dynamics 7
- Genetics top 1%
- Genomic variations and chromosomal abnormalities 16
- Genomics and Rare Diseases 10
- Co-authors
- Peter J. CampbellMichael R. StrattonMoritz GerstungKerstin HaaseIñigo MartincorenaPeter MarynenYves MoreauDavid C. Wedge
- Partner nations
- United KingdomBelgiumUnited States
In The Last Decade
Peter Van Loo
74 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Cancer Research 2.9k
- Oncology 1.8k
- Molecular Biology 4.1k
- Genetics 1.4k
- Pathology and Forensic Medicine 839
Countries citing papers authored by Peter Van Loo
This map shows the geographic impact of Peter Van Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Van Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Van Loo more than expected).
Fields of papers citing papers by Peter Van Loo
This network shows the impact of papers produced by Peter Van Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Van Loo. The network helps show where Peter Van Loo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Van Loo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 25 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 15 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 12 | |
| 9 | A pan-cancer compendium of chromosomal instabilitybreakdown → | 2022 | 135 |
| 10 | 2022 | 45 | |
| 11 | 2022 | 18 | |
| 12 | 2018 | 42 | |
| 13 | 2016 | 27 | |
| 14 | Mutational signatures associated with tobacco smoking in human cancerbreakdown → | 2016 | 680 |
| 15 | High burden and pervasive positive selection of somatic mutations in normal human skinbreakdown → | 2015 | 1123 |
| 16 | 2013 | 20 | |
| 17 | 2012 | 156 | |
| 18 | 2012 | 12 | |
| 19 | Array-CGH mapping of an overrepresented 7Q region in gamma/delta hepatosplenic T-cell lymphoma | 2008 | 1 |
| 20 | Array-CGH: A novel tool in genetic diagnosis of individuals with congenital heart defects | 2006 | 0 |
About Peter Van Loo
Peter Van Loo is a scholar working on Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 83 papers that have together received 7.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (37 papers), Genomic variations and chromosomal abnormalities (16 papers), Genomics and Rare Diseases (10 papers), Genomics and Phylogenetic Studies (9 papers), Epigenetics and DNA Methylation (8 papers), Single-cell and spatial transcriptomics (7 papers), Gene expression and cancer classification (7 papers) and Genomics and Chromatin Dynamics (7 papers). The work is most often cited by research in Cancer Research (2.9k citations), Oncology (1.8k citations) and Molecular Biology (4.1k citations). Peter Van Loo has collaborated with scholars based in United Kingdom, Belgium and United States. Frequent co-authors include Peter J. Campbell, Michael R. Stratton, Moritz Gerstung, Kerstin Haase, Iñigo Martincorena, Peter Marynen, Yves Moreau, David C. Wedge, Stein Aerts and Ludmil B. Alexandrov. Their work appears in journals such as Blood, Journal of Clinical Oncology, Nature Communications, Bioinformatics and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.